Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nambiar, P. R.
Right arrow Articles by Rosenberg, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nambiar, P. R.
Right arrow Articles by Rosenberg, D. W.
[Cancer Research 64, 6394-6401, September 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Genetic signatures of High- and Low-Risk Aberrant Crypt Foci in a Mouse Model of Sporadic Colon Cancer

Prashant R. Nambiar1,2, Masako Nakanishi1, Rishi Gupta3, Evelyn Cheung4, Ali Firouzi4, Xiao-Jun Ma4, Christopher Flynn1, Mei Dong1, Kishore Guda1, Joel Levine5, Rajiv Raja4, Luke Achenie3 and Daniel W. Rosenberg1

1 Center for Molecular Medicine and Program in Colorectal Cancer, University of Connecticut Health Center, Farmington, Connecticut; Departments of 2 Pathobiology and Veterinary Sciences and 3 Chemical Engineering, University of Connecticut, Storrs, Connecticut; 4 Arcturus Bioscience, Inc., Mountain View, California; and 5 Department of Medicine and Program in Colorectal Cancer, University of Connecticut Health Center, Farmington, Connecticut

To determine whether cancer risk is related to histopathological features of preneoplastic aberrant crypt foci (ACF), gene expression analysis was performed on ACF from two mouse strains with differing tumor sensitivity to the colonotropic carcinogen, azoxymethane. ACF from sensitive A/J mice were considered at high risk, whereas ACF from resistant AKR/J mice were considered at low risk for tumorigenesis. A/J and AKR/J mice received weekly injections of azoxymethane (10 mg/kg body weight), and frozen colon sections were prepared 6 weeks later. Immunohistochemistry was performed using biomarkers associated with colon cancer, including adenomatous polyposis coli, ß-catenin, p53, c-myc, cyclin D1, and proliferating cell nuclear antigen. Hyperplastic ACF, dysplastic ACF, microadenomas, adjacent normal-appearing epithelium, and vehicle-treated colons were laser captured, and RNA was linearly amplified (LCM-LA) and subjected to cDNA microarray-based expression analysis. Patterns of gene expression were identified using adaptive centroid algorithm. ACF from low- and high-risk colons were not discriminated by immunohistochemistry, with the exception of membrane staining of ß-catenin. To develop genetic signatures that predict cancer risk, LCM-LA RNA from ACF was hybridized to cDNA arrays. Of 4896 interrogated genes, 220 clustered into six broad clusters. A total of 226 and 202 genes was consistently altered in lesions from A/J and AKR/J mice, respectively. Although many alterations were common to both strains, expression profiles stratified high- and low- risk lesions. These data demonstrate that ACF with distinct tumorigenic potential have distinguishing molecular features. In addition to providing insight into colon cancer promotion, our data identify potential biomarkers for determining colon cancer risk in humans.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Nakanishi, D. C. Montrose, P. Clark, P. R. Nambiar, G. S. Belinsky, K. P. Claffey, D. Xu, and D. W. Rosenberg
Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis
Cancer Res., May 1, 2008; 68(9): 3251 - 3259.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
A. B Glick
The High Risk Premalignant Lesion: Experimental Evidence and Clinical Implications
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 513 - 516.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. Sasada, K. Azuma, T. Hirai, H. Hashida, M. Kanai, T. Yanagawa, and A. Takabayashi
Prognostic Significance of the Immediate Early Response Gene X-1 (IEX-1) Expression in Pancreatic Cancer
Ann. Surg. Oncol., February 1, 2008; 15(2): 609 - 617.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. B. Rogers, E. J. Theve, Y. Feng, R. C. Fry, K. Taghizadeh, K. M. Clapp, C. Boussahmain, K. S. Cormier, and J. G. Fox
Hepatocellular Carcinoma Associated with Liver-Gender Disruption in Male Mice
Cancer Res., December 15, 2007; 67(24): 11536 - 11546.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. J. Greenspan, J. L. Cyr, D. C. Pleau, J. Levine, T. V. Rajan, D. W. Rosenberg, and C. D. Heinen
Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer
Carcinogenesis, April 1, 2007; 28(4): 769 - 776.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. K. Glebov, L. M. Rodriguez, P. Soballe, J. DeNobile, J. Cliatt, K. Nakahara, and I. R. Kirsch
Gene Expression Patterns Distinguish Colonoscopically Isolated Human Aberrant Crypt Foci from Normal Colonic Mucosa.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2253 - 2262.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. J. Greenspan, M. A. Jablonski, T. V. Rajan, J. Levine, G. S. Belinsky, and D. W. Rosenberg
Epigenetic alterations in RASSF1A in human aberrant crypt foci
Carcinogenesis, July 1, 2006; 27(7): 1316 - 1322.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
P. R. Nambiar, S. M. Kirchain, K. Courmier, S. Xu, N. S. Taylor, E. J. Theve, M. M. Patterson, and J. G. Fox
Progressive Proliferative and Dysplastic Typhlocolitis in Aging Syrian Hamsters Naturally Infected with Helicobacter spp.: A Spontaneous Model of Inflammatory Bowel Disease
Vet. Pathol., January 1, 2006; 43(1): 2 - 14.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
P. R. Nambiar, S. R. Boutin, R. Raja, and D. W. Rosenberg
Global Gene Expression Profiling: A Complement to Conventional Histopathologic Analysis of Neoplasia
Vet. Pathol., November 1, 2005; 42(6): 735 - 752.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S.W. Barth, C. Fahndrich, A. Bub, H. Dietrich, B. Watzl, F. Will, K. Briviba, and G. Rechkemmer
Cloudy apple juice decreases DNA damage, hyperproliferation and aberrant crypt foci development in the distal colon of DMH-initiated rats
Carcinogenesis, August 1, 2005; 26(8): 1414 - 1421.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Krajewska, H. Kim, C. Kim, H. Kang, K. Welsh, S.-i. Matsuzawa, M. Tsukamoto, R. G. Thomas, N. Assa-Munt, Z. Piao, et al.
Analysis of Apoptosis Protein Expression in Early-Stage Colorectal Cancer Suggests Opportunities for New Prognostic Biomarkers
Clin. Cancer Res., August 1, 2005; 11(15): 5451 - 5461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-L. Kruse, A. Arlt, A. Sieke, F. Grohmann, M. Grossmann, J. Minkenberg, U. R. Folsch, and H. Schafer
Immediate Early Gene X1 (IEX-1) Is Organized in Subnuclear Structures and Partially Co-localizes with Promyelocytic Leukemia Protein in HeLa Cells
J. Biol. Chem., July 1, 2005; 280(26): 24849 - 24856.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.